Literature DB >> 9893858

Colour discrimination ellipses in patients with dominant optic atrophy.

M P Simunovic1, M Votruba, B C Regan, J D Mollon.   

Abstract

Many colour tests require a visual acuity of at least 0.1, making them unsuitable for low vision patients. To assess colour vision in patients with sub-normal acuity, we re-designed a previously described test so that its spatial details would be coarse enough to be resolvable by subjects with severe visual impairment. The test measures chromatic discrimination along 20 axes evenly spaced in CIE 1976 L*u*v* colour space. We detail the results for this test in a group of patients with dominant optic atrophy. Despite the lack of evidence for genetic heterogeneity in dominant optic atrophy, we observed phenotypic variation both between and within families.

Entities:  

Mesh:

Year:  1998        PMID: 9893858     DOI: 10.1016/s0042-6989(98)00094-7

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  12 in total

1.  Colour discrimination ellipses in choroideremia.

Authors:  Immanuel P Seitz; Jasleen K Jolly; M Dominik Fischer; Matthew P Simunovic
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-02-05       Impact factor: 3.117

2.  Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy.

Authors:  M Votruba; D Thiselton; S S Bhattacharya
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

Review 3.  A review of primary hereditary optic neuropathies.

Authors:  M Votruba; S Aijaz; A T Moore
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

4.  Cone dystrophy phenotype associated with a frameshift mutation (M280fsX291) in the alpha-subunit of cone specific transducin (GNAT2).

Authors:  M Michaelides; I A Aligianis; G E Holder; M Simunovic; J D Mollon; E R Maher; D M Hunt; A T Moore
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

5.  CNGB3-achromatopsia clinical trial with CNTF: diminished rod pathway responses with no evidence of improvement in cone function.

Authors:  Wadih M Zein; Brett G Jeffrey; Henry E Wiley; Amy E Turriff; Santa J Tumminia; Weng Tao; Ronald A Bush; Dario Marangoni; Rong Wen; Lisa L Wei; Paul A Sieving
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-09       Impact factor: 4.799

6.  Red-green color vision impairment in Duchenne muscular dystrophy.

Authors:  Marcelo Fernandes Costa; Andre Gustavo Fernandes Oliveira; Claudia Feitosa-Santana; Mayana Zatz; Dora Fix Ventura
Journal:  Am J Hum Genet       Date:  2007-04-13       Impact factor: 11.025

7.  The Pattern of Retinal Ganglion Cell Loss in OPA1-Related Autosomal Dominant Optic Atrophy Inferred From Temporal, Spatial, and Chromatic Sensitivity Losses.

Authors:  Anna Majander; Catarina João; Andrew T Rider; G Bruce Henning; Marcela Votruba; Anthony T Moore; Patrick Yu-Wai-Man; Andrew Stockman
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-01-01       Impact factor: 4.799

8.  Psychophysical Measurements of Luminance Contrast Sensitivity and Color Discrimination with Transparent and Blue-Light Filter Intraocular Lenses.

Authors:  Marcelo Fernandes da Costa; Augusto Paranhos Júnior; Claudio Luiz Lottenberg; Leonardo Cunha Castro; Dora Fix Ventura
Journal:  Ophthalmol Ther       Date:  2017-08-09

9.  Severe Loss of Tritan Color Discrimination in RPE65 Associated Leber Congenital Amaurosis.

Authors:  Neruban Kumaran; Caterina Ripamonti; Angelos Kalitzeos; Gary S Rubin; James W B Bainbridge; Michel Michaelides
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-01-01       Impact factor: 4.799

10.  Photoreceptor Structure in GNAT2-Associated Achromatopsia.

Authors:  Michalis Georgiou; Navjit Singh; Thomas Kane; Anthony G Robson; Angelos Kalitzeos; Nashila Hirji; Andrew R Webster; Alfredo Dubra; Joseph Carroll; Michel Michaelides
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-03-09       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.